Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial por Walter Suárez Carmona | Ene 27, 2025
The role of incretin receptor agonists in the treatment of obesity por Walter Suárez Carmona | Ene 27, 2025
Lipoprotein lipase as a target for obesity/diabetes related cardiovascular disease por Walter Suárez Carmona | Ene 27, 2025
